Global Neurological Biomarkers Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Published Date: 2021-01-17
- Report ID: 38708
- Pages: 108
-
Format:
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Marketss analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Neurological Biomarkers market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Neurological Biomarkers Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Neurological Biomarkers Market
Bio-Rad Laboratories
QIAGEN
Alseres Pharmaceuticals
Abbott
Thermo Fisher Scientific
Acumen Pharmaceuticals
Myriad RBM, Athena Diagnostics
AbaStar MDx
BANYAN BIOMARKERS
...
Major Type of Neurological Biomarkers Covered in Prudent Markets report:
Metabolomic
Genomic
Proteomic
Imaging
Others
Application Segments Covered in Prudent Markets Market
Multiple Sclerosis
Alzheimers Disease
Parkinsons Disease
Autism Spectrum Disorders
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Neurological Biomarkers Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Metabolomic -Product Introduction and Major Manufacturers
1.1.2 Genomic -Product Introduction and Major Manufacturers
1.1.3 Proteomic -Product Introduction and Major Manufacturers
1.1.4 Imaging -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Neurological Biomarkers Status and Prospect (2015-2026)
2.1.1 China Neurological Biomarkers Market Size and Growth Rate (2015-2026)
2.1.2 China Neurological Biomarkers Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Neurological Biomarkers Status and Prospect (2015-2026)
2.2.1 EU Neurological Biomarkers Market Size and Growth Rate (2015-2026)
2.2.2 EU Neurological Biomarkers Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Neurological Biomarkers Status and Prospect (2015-2026)
2.3.1 USA Neurological Biomarkers Market Size and Growth Rate (2015-2026)
2.3.2 USA Neurological Biomarkers Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Neurological Biomarkers Status and Prospect (2015-2026)
2.4.1 Japan Neurological Biomarkers Market Size and Growth Rate (2015-2026)
2.4.2 Japan Neurological Biomarkers Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Neurological Biomarkers Status and Prospect (2015-2026)
2.5.1 India Neurological Biomarkers Market Size and Growth Rate (2015-2026)
2.5.2 India Neurological Biomarkers Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Neurological Biomarkers Status and Prospect (2015-2026)
2.6.1 Southeast Asia Neurological Biomarkers Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Neurological Biomarkers Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Neurological Biomarkers Status and Prospect (2015-2026)
2.7.1 South America Neurological Biomarkers Market Size and Growth Rate (2015-2026)
2.7.2 South America Neurological Biomarkers Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Neurological Biomarkers Status and Prospect (2015-2026)
2.8.1 Neurological Biomarkers Market Size and Growth Rate (2015-2026)
2.8.2 Neurological Biomarkers Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Neurological Biomarkers Market Assessment by Segment
3.1 Global Neurological Biomarkers Capacity and Growth Rate
3.2 Global Neurological Biomarkers Sales by Type
3.3 Global Neurological Biomarkers Sales Revenue by Type
3.4 Global Neurological Biomarkers Consumption by Application
4 Global Neurological Biomarkers Market Assessment by Regions
4.1 Global Neurological Biomarkers Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Neurological Biomarkers Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Neurological Biomarkers Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Neurological Biomarkers Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Neurological Biomarkers Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Neurological Biomarkers Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Neurological Biomarkers Sales Market Share of Manufacturers (2019-2020)
6.3 Global Neurological Biomarkers Sales Revenue Market Share of Manufacturers (2019-2020)
7 Neurological Biomarkers Competitive Analysis
7.1 Bio-Rad Laboratories
7.1.1 Bio-Rad Laboratories Company Profiles
7.1.2 Bio-Rad Laboratories Product Introduction
7.1.3 Bio-Rad Laboratories Neurological Biomarkers Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 QIAGEN
7.2.1 QIAGEN Company Profiles
7.2.2 QIAGEN Product Introduction
7.2.3 QIAGEN Neurological Biomarkers Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Alseres Pharmaceuticals
7.3.1 Alseres Pharmaceuticals Company Profiles
7.3.2 Alseres Pharmaceuticals Product Introduction
7.3.3 Alseres Pharmaceuticals Neurological Biomarkers Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Abbott
7.4.1 Abbott Company Profiles
7.4.2 Abbott Product Introduction
7.4.3 Abbott Neurological Biomarkers Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Profiles
7.5.2 Thermo Fisher Scientific Product Introduction
7.5.3 Thermo Fisher Scientific Neurological Biomarkers Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Acumen Pharmaceuticals
7.6.1 Acumen Pharmaceuticals Company Profiles
7.6.2 Acumen Pharmaceuticals Product Introduction
7.6.3 Acumen Pharmaceuticals Neurological Biomarkers Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Myriad RBM, Athena Diagnostics
7.7.1 Myriad RBM, Athena Diagnostics Company Profiles
7.7.2 Myriad RBM, Athena Diagnostics Product Introduction
7.7.3 Myriad RBM, Athena Diagnostics Neurological Biomarkers Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 AbaStar MDx
7.8.1 AbaStar MDx Company Profiles
7.8.2 AbaStar MDx Product Introduction
7.8.3 AbaStar MDx Neurological Biomarkers Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 BANYAN BIOMARKERS
7.9.1 BANYAN BIOMARKERS Company Profiles
7.9.2 BANYAN BIOMARKERS Product Introduction
7.9.3 BANYAN BIOMARKERS Neurological Biomarkers Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
8 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
